GlassScriptPhysician profile
Dennis C Friedman
NPI 1922036359
$6,481.34
in general payments reported to CMS, 2019-2025
37 companies · $774 in 2025
The $774 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $783 · 2021: $1,131 · 2022: $668 · 2023: $1,522 · 2024: $736 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,916 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,916.39 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $882.78 | 2019-2025 | Farxiga, Lokelma |
| Amgen INC. | $874.01 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $573.05 | 2020-2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $522.49 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $388.86 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $374.25 | 2019-2024 | Xarelto |
| Pfizer INC. | $280.27 | 2019-2025 | |
| Novo Nordisk INC | $278.82 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Boston Scientific Corporation | $272.60 | 2019-2023 | Watchman Access System |
| Merck Sharp & Dohme LLC | $246.41 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $228.45 | 2019-2025 | |
| Edwards Lifesciences Corporation | $217.47 | 2019-2022 | |
| Amarin Pharma, INC. | $197.97 | 2019-2021 | |
| Cvrx, INC. | $175.20 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $138.70 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $132.46 | 2019-2020 | |
| Irhythm Technologies, INC. | $102.55 | 2024 | Zio Monitor, Zio Xt Patch |
| Abiomed | $77.36 | 2024-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $64.96 | 2019-2022 | |
| Philips North America LLC | $61.62 | 2019-2023 | |
| Inari Medical, INC. | $57.42 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals International, Plc | $39.99 | 2024 | Arcalyst |
| Medtronic, INC. | $35.16 | 2023 | Symplicity G3 |
| Lexicon Pharmaceuticals, INC. | $34.01 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $33.24 | 2024-2025 | Assure Wcd |
| Atricure, INC. | $31.88 | 2023-2024 | |
| Astellas Pharma US INC | $24.64 | 2019 | |
| Becton, Dickinson and Company | $23.04 | 2019 | |
| Scpharmaceuticals INC. | $22.84 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.74 | 2019 | |
| Azurity Pharmaceuticals, INC. | $20.34 | 2023 | Edarbi |
| Bayer Healthcare Pharmaceuticals INC. | $19.26 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.17 | 2023 | Jardiance |
| Bardy Diagnostics, INC. | $10.33 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.